Clinical Trials Directory

Trials / Terminated

TerminatedNCT01799395

Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer

Prevalence, Incidence and Predictors of Central Airway Obstruction in Patients With Advanced Lung Cancer

Status
Terminated
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Maggiore Bellaria Hospital, Bologna · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Lung cancer may cause central airway obstruction through several different mechanisms (invasion by the primary tumor, invasion by metastatic lymph nodes, airway metastasis). The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.

Conditions

Timeline

Start date
2013-02-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2013-02-26
Last updated
2017-09-12

Locations

5 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT01799395. Inclusion in this directory is not an endorsement.

Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer (NCT01799395) · Clinical Trials Directory